BioSpace News Archive

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, announced it has been nominated for the prestigious Prix Galien Startup Award.

via NewMediaWire – Sono-Tek Corporation, the leading developer and manufacturer of ultrasonic coating systems, announced that it held its Annual Shareholders Meeting on August 18, 2022 at the Company’s headquarters in Milton, New York.

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the 17th Annual Wells Fargo Securities Healthcare Conference.

Henry Schein, Inc. announced the publication of its 2021 Sustainability and Corporate Social Responsibility Report, titled “BOLD Leadership for a Healthier World.” The Company’s 2021 Sustainability and CSR Report details work done over the past year to advance its environmental, social, and governance stewardship, including expanded ESG disclosures, several distinct health equity initiatives, and continued collaborations with business partners and suppliers to help address climate change.

Mr Yuen has excelled in his previous experience as a CEO and sits on the board of directors of numerous companies that have achieved market capitalizations of over $100M CAD

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that data from the core period of the pivotal Phase 3 ACTIVATE-T study of PYRUKYND® (mitapivat) in adults with pyruvate kinase (PK) deficiency who receive regular transfusions were published on August 18, 2022, in The Lancet Haematology.

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), today announced that a Marketing Authorization Application (MAA) for pegzilarginase for the treatment of Arginase 1 Deficiency (ARG1-D) has been submitted to and successfully validated by the European Medicines Agency (EMA).

Greenhouse gas emissions intensity lowered by 16% and plastic footprint down 9.6% vs. 2020 Commitment to ambitious climate goals: Net-zero by 2050, Scope 1 and 2 emissions down 42% by 2030 Widening access to healthcare in high-burden, low-resource countries.

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, announced the grant of inducement equity awards to the company’s newly appointed chief financial officer, Geoffrey Porges, MBBS.

NEXGENRX INC. (“NexgenRx” or the “Company”) is pleased to announce its interim financial results for the second quarter ended June 30, 2022, highlighted by continued revenue growth, positive EBIDTA and increased free cash flow.